SEC Form 4 · accession 0001562180-18-000370
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Teresa L. Kline
Director
Period of report
Jan 17, 2018
Accepted (ET)
Jan 19, 2018 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F1 | $33.95 | Jan 17, 2018 | A | 2,797 | A | — | Jan 16, 2028 | Common Stock | 2,797 | 2,797 | D |
Explanation of responses
- F1The shares subject to the option vest in 12 equal monthly installments commencing on January 1, 2018.